Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage

Jay U Howington1, Scott C Kutz, Gregory E Wilding

  • 1Department of Neurosurgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.

Journal of Neurosurgery
|August 20, 2003
PubMed

Insights

Cocaine use significantly worsens outcomes for patients with aneurysmal subarachnoid hemorrhage (SAH), increasing the risk of cerebral vasospasm and poor neurological recovery. This drug

Area of Science:

  • Neurosurgery
  • Neurology
  • Toxicology

Background:

  • Aneurysmal subarachnoid hemorrhage (SAH) is a critical neurological condition with significant morbidity and mortality.
  • Cocaine is a potent stimulant with known vasoactive properties that may impact cerebrovascular events.

Purpose of the Study:

  • To investigate the association between cocaine use and clinical outcomes in patients presenting with aneurysmal SAH.
  • To determine if cocaine use independently influences the risk of cerebral vasospasm and functional recovery after SAH.

Main Methods:

  • Retrospective review of 108 patients with aneurysmal SAH treated between 1996 and 2001.
  • Analysis of patient demographics, clinical presentation (Hunt and Hess grade, Fisher grade), and substance use history (including cocaine).
  • Assessment of outcomes using the Glasgow Outcome Scale (GOS), with a focus on the incidence of vasospasm and dichotomized GOS scores.

Main Results:

  • Cocaine users (33.3%) had a significantly higher incidence of severe presentation (Hunt and Hess grade IV-V) compared to non-users (p < 0.0001).
  • Cocaine use was associated with a 2.8-fold increased risk of developing cerebral vasospasm (p < 0.0001) and a 3.3-fold increased risk of poor outcome (GOS 1-3) (p < 0.0001).
  • The negative impact of cocaine on outcomes was independent of Hunt and Hess grade and the presence of vasospasm.

Conclusions:

  • Cocaine use adversely affects both the presentation and outcome of aneurysmal SAH.
  • The vasoactive properties of cocaine likely exacerbate SAH-related complications, particularly cerebral vasospasm.
  • Cocaine use should be considered a significant factor, equivalent to major systemic illness, in assessing SAH patient prognosis.
Abstract